Loading clinical trials...
Loading clinical trials...
A Phase 1, Two-Part, Open-label Study in Healthy Adult Volunteers to Assess a Single Dose of Vadadustat as a Victim in Drug-Drug Interactions With Cyclosporine, Probenecid and Rifampin
Conditions
Interventions
vadadustat
Rifampin
+2 more
Locations
1
Canada
inVentiv Health Clinique Inc.
Québec, Quebec, Canada
Start Date
July 20, 2018
Primary Completion Date
August 15, 2018
Completion Date
August 15, 2018
Last Updated
March 22, 2019
NCT02191358
NCT01324752
NCT01477424
Lead Sponsor
Akebia Therapeutics
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions